ABBOTT LABORATORIES (ABL.DE) Stock Price, Quote, News and Overview
FRA:ABL - Deutsche Boerse Ag - US0028241000 - Common Stock - Currency: EUR
ABL.DE Quote, Performance and Key Statistics
FRA:ABL (5/23/2025, 4:43:05 PM)
115.58
-1.06 (-0.91%)
The current stock price of ABL.DE is 115.58 EUR. In the past month the price increased by 2.53%. In the past year, price increased by 21.56%.
ABL.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1ISRG.MI | INTUITIVE SURGICAL INC | 73.88 | 179.01B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 71.29 | 172.72B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 38.66 | 136.67B | ||
| 1MDT.MI | MEDTRONIC PLC | 16.17 | 97.91B | ||
| 2M6.DE | MEDTRONIC PLC | 15.25 | 92.30B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.86 | 52.46B | ||
| BOX.DE | BECTON DICKINSON AND CO | 12.24 | 43.79B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 29.24 | 39.54B | ||
| DC4.DE | DEXCOM INC | 51.4 | 29.43B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 15.87 | 20.28B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.02 | 19.20B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 14.76 | 18.86B |
Related stock screener links
About ABL.DE
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS US
Employees: 114000
Phone: 12246676100
ABBOTT LABORATORIES / ABL.DE FAQ
What is the stock price of ABBOTT LABORATORIES today?
The current stock price of ABL.DE is 115.58 EUR. The price decreased by -0.91% in the last trading session.
What is the ticker symbol for ABBOTT LABORATORIES stock?
The exchange symbol of ABBOTT LABORATORIES is ABL and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is ABL.DE stock listed?
ABL.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for ABBOTT LABORATORIES stock?
32 analysts have analysed ABL.DE and the average price target is 126.87 EUR. This implies a price increase of 9.77% is expected in the next year compared to the current price of 115.58. Check the ABBOTT LABORATORIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ABBOTT LABORATORIES worth?
ABBOTT LABORATORIES (ABL.DE) has a market capitalization of 200.45B EUR. This makes ABL.DE a Mega Cap stock.
How many employees does ABBOTT LABORATORIES have?
ABBOTT LABORATORIES (ABL.DE) currently has 114000 employees.
What are the support and resistance levels for ABBOTT LABORATORIES (ABL.DE) stock?
ABBOTT LABORATORIES (ABL.DE) has a support level at 113.39 and a resistance level at 116.74. Check the full technical report for a detailed analysis of ABL.DE support and resistance levels.
Is ABBOTT LABORATORIES (ABL.DE) expected to grow?
The Revenue of ABBOTT LABORATORIES (ABL.DE) is expected to grow by 6.4% in the next year. Check the estimates tab for more information on the ABL.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ABBOTT LABORATORIES (ABL.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ABL.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ABL.DE, evaluating the profitability, health, valuation and growth aspects
- ABBOTT LABORATORIES (ABL.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ABBOTT LABORATORIES (ABL.DE) Sales and EPS estimates to see what analysts future expectations are.
- ABBOTT LABORATORIES (ABL.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ABBOTT LABORATORIES (ABL.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- ABBOTT LABORATORIES (ABL.DE) Stock Chart to make your own analysis
- ABBOTT LABORATORIES (ABL.DE) Latest news and press-releases to stay up to date.
Does ABBOTT LABORATORIES (ABL.DE) stock pay dividends?
ABBOTT LABORATORIES (ABL.DE) has a dividend yield of 1.77%. The yearly dividend amount is currently 1.98. Check the full fundamental report for a detailed analysis of ABL.DE dividend history, reliability and sustainability.
When does ABBOTT LABORATORIES (ABL.DE) report earnings?
ABBOTT LABORATORIES (ABL.DE) will report earnings on 2025-07-16, before the market open.
What is the Price/Earnings (PE) ratio of ABBOTT LABORATORIES (ABL.DE)?
The PE ratio for ABBOTT LABORATORIES (ABL.DE) is 27.32. This is based on the reported non-GAAP earnings per share of 4.23 and the current share price of 115.58 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ABL.DE.
ABL.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to ABL.DE. When comparing the yearly performance of all stocks, ABL.DE is one of the better performing stocks in the market, outperforming 76.52% of all stocks.
ABL.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE. ABL.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
ABL.DE Financial Highlights
Over the last trailing twelve months ABL.DE reported a non-GAAP Earnings per Share(EPS) of 4.23. The EPS increased by 8.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.89% | ||
| ROA | 16.58% | ||
| ROE | 27.66% | ||
| Debt/Equity | 0.26 |
ABL.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to ABL.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.
For the next year, analysts expect an EPS growth of 11.56% and a revenue growth 6.4% for ABL.DE